Navigation Links
VirtualScopics Receives Further Extension to Regain Compliance With Nasdaq
Date:3/25/2009

Additional deferral of bid price requirement gives Company until November 2009

ROCHESTER, N.Y., March 25 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSCP) today announced that The Nasdaq Stock Market has informed the Company that it has further extended the temporary suspension of the $1.00 minimum bid price requirement until July 20, 2009. As a result of the rule suspension by Nasdaq, VirtualScopics now has until November 9, 2009 to regain compliance with the minimum $1.00 share bid price requirement instead of the previously reported date of July 10, 2009.

The Company received stockholder approval to effectuate a reverse stock split, through May 9, 2009, in the event that the minimum bid price has not been achieved. Because of the further deferral by Nasdaq, the Company's intention is to request an extension from its stockholders to take advantage of the additional time allowed by Nasdaq to regain compliance.

About VirtualScopics, Inc.

VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster. For more information about VirtualScopics, visit www.virtualscopics.com.

Forward-Looking Statements

The statements contained in this press release that are not purely historical are forward-looking statements within the me
'/>"/>

SOURCE VirtualScopics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference
2. VirtualScopics Backlog Rises to a Record $27 Million
3. VirtualScopics Reports Record Third Quarter 2008 Revenue and Gross Profit
4. VirtualScopics to Present at Two Upcoming Investor Conferences
5. VirtualScopics Schedules Third Quarter 2008 Earnings Announcement
6. VirtualScopics Reports Second Quarter 2008 Results
7. VirtualScopics Receives NASDAQ Delisting Notice; Company Files Appeal to Stay Delisting
8. VirtualScopics Backlog Exceeds a Record $20 Million
9. VirtualScopics Announces $4.35 Million Private Placement
10. NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System
11. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 ALS Insights is a ... and comfort. It features a series of compelling interviews ... They share their insights, in searing honesty, about issues ... impact on children, what happened in the final days ... Challenge has created a dramatic increase in public awareness ...
(Date:8/27/2014)... Lake City, Utah (PRWEB) August 27, 2014 ... in advancing the business of healthcare, is pleased ... , a ground-breaking online recruitment resource specifically designed ... hiring is undergoing significant changes. To help address ... aging workforce, and tighter budgets—AAPC launched CareerHealth.com ...
(Date:8/27/2014)... CT (PRWEB) August 27, 2014 ... cyclists of all abilities to go the distance this ... Alex’s Million Mile – Run. Walk. Ride. initiative, hosted ... and increase awareness of childhood cancer. September represents ... year’s Alex’s Million Mile, Inspira Marketing Group has teamed ...
(Date:8/27/2014)... August 27, 2014 IntelliSoft Group, LLC, ... management software, will unveil IntelliCred, IntelliApp and ... of Medical Staff Services (NHAMSS) Annual Conference on September ... in Bedford, NH. , Notable improvements available in ... , Contract Linking: A new Contract Connection ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 A recently ... discusses the importance of time in correcting coagulopathy to ... on a variety of anticoagulants and examines medical conditions ... to the research, although anticoagulants have been approved by ... systemic embolism, they are also known to affect the ...
Breaking Medicine News(10 mins):Health News:ALS Insights Launched as Web Resource of Interviews and Information 2Health News:AAPC Responds to Healthcare Workforce Challenges with CareerHealth.com 2Health News:AAPC Responds to Healthcare Workforce Challenges with CareerHealth.com 3Health News:Alex’s Lemonade Stand Foundation Kicks Off Alex’s Million Mile – Run. Walk. Ride. with Labor Day 5k Run in New York City’s Hudson River Park 2Health News:Alex’s Lemonade Stand Foundation Kicks Off Alex’s Million Mile – Run. Walk. Ride. with Labor Day 5k Run in New York City’s Hudson River Park 3Health News:IntelliSoft Group to Unveil Version 14.2 of IntelliCred, IntelliApp and IntelliContract at the New Hampshire Association of Medical Staff Services Annual Conference 2Health News:Flood Law Group Comments on Recent AAICH Study 2
... treatment for recurrent Clostridium difficile infection (CDI), ... the official journal of the American Gastroenterological Association. Additionally, ... to be greater than in some previously reported series, ... rather safe procedure. CDI is a common cause of ...
... 14, 2012Research!America will honor some of our nation,s foremost ... Advocacy Awards tonight at the Andrew W. Mellon Auditorium ... leaders from government, industry, academia and health advocacy organizations ... have made an impact in advancing the nation,s commitment ...
... (HealthDay News) -- High school and college students around the country ... on vacation can ruin the fun. The American College of ... prevent injuries and stay safe while traveling with their friends or ... should go to the nearest ER so we can treat them," ...
... (HealthDay News) -- The drug misoprostol reduced major complications ... a new study. Doctors often use misoprostol for ... now, however, there were no studies large enough to ... complications, either immediate or delayed, according to background information ...
... , WEDNESDAY, March 7 (HealthDay News) -- Researchers report that ... system in patients who received kidney transplants, a process that ... organ instead of trying to reject it. There are ... number of patients. Also, the required procedure is expensive and ...
... Treatment with the common diabetes drug metformin appears ... infected with HIV. In a presentation today ... Infections, Massachusetts General Hospital (MGH) researchers reported that ... essentially no progression of coronary artery calcification during ...
Cached Medicine News:Health News:A new treatment option for Clostridium difficile: Fecal transplantation 2Health News:Research!America honors leading health research advocates 2Health News:Spring Break Safety Tips to Keep Vacation Fun 2Health News:Drug Reduces Complications in Surgical Abortions: Study 2Health News:Transplant Procedure Creates 'Hybrid' Immune System to Combat Rejection 2Health News:Transplant Procedure Creates 'Hybrid' Immune System to Combat Rejection 3Health News:Diabetes drug halts atherosclerosis progression in HIV-infected patients 2Health News:Diabetes drug halts atherosclerosis progression in HIV-infected patients 3
(Date:8/26/2014)... 2014  Actavis plc (NYSE: ACT ), a ... Saunders , CEO and President of Actavis, will provide an ... Stanley Global Healthcare Conference 2014 in New York, ... The presentation will take place on Tuesday, September ... Hyatt New York, 109 East 42 nd Street, ...
(Date:8/26/2014)... Research and Markets  has announced the ... 2014-2018" report to their offering. Intranasal ... the administration of drugs for the treatment of local ... allergic and non-allergic rhinitis and sinusitis. The nose is ... vaccination and systematic drug delivery. Continuous ...
(Date:8/26/2014)... comes to diabetes supplies, innovations are often accused of ... answer a real medical need. Fitting ... shows how long it,s been since your last injection. ... insulin doses. Very easy to use, Timesulin starts automatically ... after an injection. There is no settings or complicated ...
Breaking Medicine Technology:Actavis to Present at Morgan Stanley Global Healthcare Conference 2014 2Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 2Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 3Montméd obtains reimbursement of Timesulin, the smart insulin pen timer cap, by major insurance companies in Canada 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: